Abstract
The regulatory requirements concerning drugs involve quality, efficacy and safety. These matters are dealt with in national, international and supranational rules and regulations (e.g. 1).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
The rules governing medicaments for human use in the European Community. 111/182/87. February 1987.
Kristensen K, Norbygaard E (eds.). Safety and efficacy of radiopharmaceuticals. Martinus Nijhoff Publ. 1984.
EEC Council Directive 87/22/EEC of 22.12.86 relating to the placing on the market of high technology medicinal products particularly those derived from biotechnology.
EEC Notes to applicants for marketing authorizations on requirements for the production and quality control of me-dicinal products derived by recombinant DNA technology . Draft, January 1987
EEC Notes to applicants for marketing authorizations on the requirements for the preclinical biological safety testing of medicinal products derived from biotechnology. Draft, March 1987.
Radiopharmaceuticals. Drug Applications. Nordic guidelines. Draft, Nordic Council on Medicines, January 1987
EEC Recommended basis for the conduct of clinical trials of medicinal products in the European Community . Draft, March 1987.
Hampton JR. The end of clinical freedom. Brit med J 1983; 287: 1237–1238.
Hammermaier A, Reich., Bögl W. Qualitätskontrolle von in- vivo Radiopharmaka. Institut für Strahlenhygiene, Bundes-gesundheitsamt, 1986.
Lasagna L. Clinical testing of products prepared by bio-technology. Regulatory Tox Pharmacol 1986; 6: 385–390.
Clinical Trials of Drugs. Nordic guidelines. Nordic Council on Medicines Publication no. 11, 1983.
Juul P . Clinical trials of radiopharmaceuticals. In Kristensen K, Norbygaard E (eds.): Safety and efficacy of ra-diopharmaceuticals. Martinus Nijhoff Publ. 1984: 179–190
Towards an international ethic for research involving human subjects. Report of the summit bioethics conference, Ottawa, 1987 (in press).
Lasagna L. On reducing waste in foreign clinical trials and postregulation experience. Clin Pharmacol Ther 1986; 40: 269–372.
Drug Applications. Nordic guidelines. Nordic Council on Medicines Publication no. 12, 1983.
Notice to applicants for marketing authorizations for proprietary medicinal products in the member states of the European Community. Ill/158/54. (Revision 1987 ).
Levine RJ . Ethics and regulation of clinical research. Urban & Schwarzenberg 1986 (2. ed.)
Walker SR & Asscher AW (eds.). Medicines and risk/benefit decisions. MTP Press Ltd. 1987.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 Martinus Nijhoff Publishers, Dordrecht
About this chapter
Cite this chapter
Dige-Petersen, H., Juul, P. (1987). Current Trends in the Requirements for Safety and Efficacy of New Drugs. In: Kristensen, K., Nørbygaard, E. (eds) Safety and Efficacy of Radiopharmaceuticals 1987. Developments in Nuclear Medicine, vol 14. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-3375-0_22
Download citation
DOI: https://doi.org/10.1007/978-94-009-3375-0_22
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-8016-3
Online ISBN: 978-94-009-3375-0
eBook Packages: Springer Book Archive